Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors

Cetuximab and panitumumab are two distinct monoclonal antibodies (mAbs) targeting the epidermal growth factor receptor (EGFR), and both are widely used in combination with chemotherapy or as monotherapy to treat patients with RAS wild-type metastatic colorectal cancer. Although often considered inte...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Foncillas, Jesús, Sunakawa, Yu, Aderka, Dan, Wainberg, Zev, Ronga, Philippe, Witzler, Pauline, Stintzing, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763619/
https://www.ncbi.nlm.nih.gov/pubmed/31616627
http://dx.doi.org/10.3389/fonc.2019.00849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763619/
https://www.ncbi.nlm.nih.gov/pubmed/31616627
http://dx.doi.org/10.3389/fonc.2019.00849

Ejemplares similares